---
Type: Solution-Profiling-Results
Stage: ASSESSMENT-02
Business: HEAD
Status: Active
Created: 2026-02-20
Updated: 2026-02-20
Method: live deep-research run — supersedes back-propagated version of same date
Prompt-artifact: docs/business-os/strategy/HEAD/2026-02-20-solution-profiling-prompt.md
Downstream: docs/business-os/strategy/HEAD/2026-02-20-solution-decision.user.md
ASSESSMENT-03-note: ASSESSMENT-03 was produced from the back-propagated version; live research confirms Option 1 selection and makes two corrections documented in solution-select.user.md
Owner: Pete
Review-trigger: After each completed build cycle touching this document.
---

# Solution Space Research Results — HEAD (ASSESSMENT-02)

*Live deep-research run output. Verbatim. Two corrections to the back-propagated ASSESSMENT-03 evaluation have been applied in `solution-select.user.md`.*

---

## Situation summary and research framing

The downstream DISCOVERY/S2 artefacts you provided centre on a practical, recurring "retention + organisation + personalisation" problem for people who wear externally mounted cochlear implant (CI) sound processors: the external processor sits behind the ear, transmits to an antenna/coil held by a magnet, and is powered by a battery—creating multiple points of loss, discomfort, snagging, and "kid removes it" failure modes.

Two contextual signals matter for HEAD's ASSESSMENT-03 option selection:

First, the addressable installed base is non-trivial and growing. In Italy, a population-based study (2001–2023) found cochlear implant procedures rising from 537 in 2001 to 1,595 in 2023, alongside broader growth in implanted hearing devices. Globally, hearing loss is widespread (the World Health Organization estimates 430 million people require rehabilitation for disabling hearing loss), and cochlear implantation is commonly cited at the "~1 million implants implanted worldwide" order of magnitude (for example, in a MED-EL press statement and in peer-reviewed synthesis).

Second, the key execution constraint embedded in your S0B summary—startup-speed delivery (3–6 months), with minimal regulatory drag—interacts sharply with how EU law defines "intended purpose" and "accessory for a medical device." Under Regulation (EU) 2017/745, "intended purpose" is determined by what the manufacturer states on the label, IFU, and promotional/sales materials, and an "accessory for a medical device" is an article intended to enable the medical device to be used in accordance with its intended purpose or to assist its medical functionality. This creates a real (manageable but not ignorable) compliance branch for Option 1.

Against that framing, the deep-research questions that most affect ASSESSMENT-03 are:

- Is there clear evidence that retention headbands and related accessories are a recurring need with proven willingness-to-pay and discoverable distribution channels?
- Is the "Italy / Italian-language gap" real, or is it better described as a "fragmented, medically coded retail gap" rather than "no local option exists"?
- What is the realistic regulatory/safety posture for a cross-compatible textile accessory line sold into the EU, especially for children?

---

## Evidence of the retention-and-accessories need

Clinical and manufacturer materials treat "keeping processors in place" as a practical, persistent issue, and they already describe the product archetypes HEAD is proposing.

A UK NHS hospital trust publishes a patient information page explicitly recommending "headbands with pockets" to keep hearing devices in place, adding a functional requirement: breathable material to avoid overheating the skin around the ear. It also lists third-party headband providers (including Hearing Henry and Ear Suspenders) and separately discusses cords/clips as retention aids. This is strong corroboration that (a) the problem exists in routine care and (b) third-party purchase is common (i.e., not all solutions are NHS-supplied).

Manufacturers also provide and market retention accessories directly:

- Cochlear markets retention options "especially during physical activities and sports," with multiple retention products for behind-the-ear processors.
- Cochlear's own headband is described as a retention option with a built-in anti-slip strip, designed for children or adults during physical activities, and includes a head-circumference sizing chart.
- MED-EL groups "fixation options" (clips, hooks, headbands) as "extra security," and its sports headband description closely matches Option 1's design language: special pockets, breathable fabric, and protection from sweat/moisture.

These sources jointly support the ASSESSMENT-02 inference that retention products are not a niche invention: they are a recognised category with clear functional specs (pockets; breathability; sweat management; anti-slip) and use cases (active kids; sports; daily wear).

---

## Competitive landscape and channel validation

The market is active across three layers: (a) small but scaled independent sellers (often Etsy-led), (b) manufacturer accessory catalogues, and (c) specialist hearing retailers/distributors. This triangulation matters because it demonstrates both willingness-to-pay and multiple plausible acquisition channels beyond paid ads.

### Independent sellers on Etsy show sustained demand at meaningful scale

One salient "proof of category" is how far certain makers have scaled, even within a niche:

- Geniebands' Etsy shop shows 9,156 sales and 500 reviews, with copy emphasising "premium quality Oeko‑Tex-certified fabric," and a stated worldwide customer base across 35+ countries.
- Ear Suspenders appears substantially larger: an Etsy listing snippet shows ~29.9k sales, 4.7 rating with ~2.1k reviews, and "on Etsy since 2011." Its core product proposition is consistent and functional (adjustable sizing, silicone grip, non-slip), with a flagship price point around $18.50–$19.50 depending on listing/site context.

This evidence supports your ASSESSMENT-02 assertions about "proven distribution channels" and "launchable by small team" for textile accessories—but it also shows the competitive bar: the category already contains sellers with years-long reputations, thousands of reviews, and operational maturity.

### Manufacturer and specialist retail ecosystems are already selling adjacent products

The manufacturer accessory layer matters because it crowds certain value propositions (and sets reference expectations for safety copy):

- Cochlear sells multiple safety line variants, and at least one safety line product page includes a blunt constraint: "Not suitable for use by children."
- Cochlear also sells "Bilateral Identification Adhesive Labels" (colour-coded stickers to differentiate left/right processors), validating "identity patch/label packs" as a real accessory category.
- Cochlear sells a storage case positioned as protecting processors/cables/accessories and being "large enough to hold two sound processors," validating organiser/carry products as part of the ecosystem.

In Italy specifically, the "no local option exists" claim does not hold in a literal sense. At minimum, there is an Italian-language retail listing for a "SmartEAR" universal cotton headband for cochlear implants, priced at €18, explicitly describing side pockets and child use cases. There is also an Italian B2B/B2B2C hearing-products distributor cataloguing anti-loss accessories, including Cochlear safety lines and MED-EL protective cases, behind a login-to-see-price pattern.

The more defensible gap hypothesis is therefore narrower: Italy has Italian-language availability through hearing retailers and marketplaces, but appears to have limited lifestyle-coded, brand-cohesive, cross-compatible DTC positioning (especially in the style/identity layer) compared with the rich English-language Etsy/DTC ecosystem.

### Cross-compatibility is a differentiator, but it already exists in some segments

Option 1's "cross-compatible across brands" premise is credible, yet not unique. Ear Gear explicitly positions a CI cover product line as fitting multiple processor ecosystems (Cochlear, Advanced Bionics, Oticon Medical, MED‑EL), and lists specific model compatibilities, framing benefits as protection from sweat/dirt/moisture/wind/loss without sacrificing sound quality.

Where a defensible wedge still exists is not "cross-compatibility alone," but rather "cross-compatibility + textile lifestyle design language + coherent range architecture in Italian/EU context," with strong attention to safety disclaimers and sizing UX.

### Community channels that plausibly support referral-based acquisition

The ASSESSMENT-02 claim about community distribution has support, but the most "official" channel evidence may differ from what was implied. MED‑EL's corporate community page explicitly directs users to "Hearpeers," describing it as an international hearing implant community providing peer support and group discussion. (This suggests that "HearPeers" is not just a generic forum name: it is a promoted community asset in the manufacturer ecosystem.)

In Italy, there are established CI user associations and charity ecosystems that can function as hubs of trust and word-of-mouth, such as APIC Associazione Portatori Impianto Cocleare, described as a non-profit volunteer association founded in Turin. This does not automatically translate into scalable CAC-efficient acquisition, but it does support the claim that identifiable "nodes" exist for partnership outreach and qualitative discovery.

---

## Regulatory and safety constraints for an EU launch

This is the section where the ASSESSMENT-02 back-propagated confidence should be "high on opportunity, medium on regulatory simplification." The key is not that Option 1 is impossible, but that the "non-medical positioning is achievable" claim has a relatively narrow safe operating space.

### Accessory risk under EU MDR is driven by intended purpose, not materials

Under the EU Medical Device Regulation (Regulation (EU) 2017/745), an "accessory for a medical device" is defined by whether the manufacturer intends it to be used with one or more particular medical devices to enable use in accordance with intended purpose or to directly assist medical functionality. Separately, "intended purpose" is what the manufacturer states across labelling, instructions for use, promotional/sales materials, and clinical evaluation statements.

Implication (inference, grounded in the definition): if HEAD markets a headband as specifically enabling a CI processor to be worn/used as intended (rather than as a general clothing accessory), it increases the likelihood regulators could treat it as an MDR accessory in scope.

If it is treated as an MDR Class I device/accessory, that pathway may still be "startup-manageable," but it is not zero-cost. The European Commission provides a "step-by-step approach for Class I medical device compliance," emphasising integration into a quality management system, technical documentation, clinical evaluation, CE marking, and registration in Eudamed.

A time-sensitive detail for HEAD's 2026 timing: Belgium's medicines and health products authority notes that Eudamed actor registration is voluntary before 28 May 2026 and mandatory from that date (linked to a Commission decision on Eudamed). Even if some MDR modules remain staged, the claimed direction-of-travel is toward mandatory participation around HEAD's launch year.

### Child safety and strangulation risk is not theoretical in this category

Your ASSESSMENT-02 artefact correctly flags "tether/lanyard child safety." Manufacturer safety documentation explicitly warns about strangulation risk from long cables (including coil or accessory cables), aimed at parents/carers. Cochlear product pages also contain "not suitable for use by children" notices for certain safety lines, and Cochlear guidance warns that retention lines longer than the standard safety line are not recommended for children because they may present strangulation risk.

Separately, EU consumer safety work on cords/drawstrings highlights strangulation and entrapment hazards and references the EN 14682 standard for children's clothing cords/drawstrings. While EN 14682 is not "about CI retention lines" per se, it reinforces the same hazard class regulators and test labs take seriously for products around children's neck/head regions.

Implication for Option 1's initial range: a textile-only "pocket headband + organiser pouch + labels/patches" line plausibly keeps risk lower than adding any corded retention component in v1, particularly if children are an explicit segment.

### General Product Safety Regulation applies regardless of MDR status

Even if HEAD successfully positions products outside MDR scope, EU consumer safety obligations still apply. The EU's 2023 General Product Safety Regulation (Regulation (EU) 2023/988) is applicable from 13 December 2024 and replaces the prior General Product Safety Directive. For HEAD, the operational meaning is: a documented safety mindset (hazard identification, traceability, clear warnings/instructions where needed) is required for children's wearable products even when "not medical."

### Textile compliance in Italy/EU is real work but standardisable

On textiles, two obligations are especially salient at ASSESSMENT-03:

- Labelling rules: Italy-facing retailers note that labels must display fibre composition according to Regulation (EU) 1007/2011, provided in Italian, without acronyms/abbreviations, and in descending order of proportion.
- Chemical safety: REACH-driven obligations around substances of very high concern (SVHCs) include duty-to-communicate requirements when candidate list substances exceed thresholds in articles, and SCIP-related information infrastructure exists for article notifications.

These are not unique to CI accessories; they are the baseline for any EU textile accessory brand, which supports the ASSESSMENT-02 claim that the compliance work is "standard," but also suggests HEAD should not treat it as "free."

---

## Supply chain and product feasibility

The evidence base supports technical feasibility for a small team, but also suggests that the best early strategy is to buy learning fast rather than over-invest in bespoke tooling.

### Manufacturing pathways with low minimums exist for headbands and personalisation elements

For textile headbands, there are production models that require minimal upfront inventory:

- Print-on-demand fulfilment providers explicitly advertise made-on-demand headbands with "no minimums," allowing early SKU testing without holding stock (albeit usually at higher unit cost).
- Custom product suppliers also advertise "no minimum order quantity" for headbands, supporting the ASSESSMENT-02 feasibility claim that initial launches can be executed without large MOQs.

For identity/personalisation components, the market shows standard bulk pathways with predictable constraints. For example, an embroidered patch product listing posts MOQ 100 and lead time "30+ working days," which matches the general expectation that embroidered/woven elements can be sourced reliably with modest volume commitments.

### Material and comfort specs are explicitly articulated by incumbents

Breathability and sweat/moisture management are not just "nice-to-have"; incumbents state them explicitly:

- The NHS guidance warns that headbands should be breathable to prevent the skin around the ear getting too hot.
- MED-EL describes its sports headband as breathable and protective against sweat/moisture, and Hearing Henry highlights fabric selection and a "flat" design that keeps processor and coil together.

This matters because it narrows the "feature surface" of a credible core product: any HEAD headband that is not breathable and comfortable will be competing against product narratives already taught by clinicians and manufacturers.

### Certification signals are already used as quality shorthand

Geniebands explicitly uses "Oeko‑Tex-certified fabric" in its Etsy shop announcement, suggesting that human-ecological textile safety markers already resonate (or at least are considered persuasive) within this niche. Independently, OEKO‑TEX describes STANDARD 100 as a label for textiles tested for harmful substances across the production chain.

In practice, this supports your ASSESSMENT-02 assumption that "Oeko‑Tex/breathable" is not just a sourcing detail but a marketable trust marker—especially for products used by infants and children.

---

## Option assessment and ASSESSMENT-03 implications

### Option 1 remains the strongest opportunity, with two corrections

The market evidence strongly supports the idea that retention headbands, pouches/cases, and identification labels/skins are established accessory categories with demonstrated purchase behaviour across multiple channels: manufacturer stores, specialist hearing retailers, and high-scale Etsy sellers.

Two adjustments are warranted versus the back-propagated ASSESSMENT-02 text:

1. **"No Italian-language equivalent identified" should be revised to a more precise thesis.** Italian-language retail options exist (e.g., a €18 cotton pocket headband sold in Italian through an Italian hearing-products retailer), and Italian distributor catalogues include retention/anti-loss accessories. The defensible gap is more likely "no cohesive, lifestyle-coded, cross-compatible DTC brand with a coherent range and Italian-first UX," rather than "no product exists."

2. **"Non-medical positioning via copy discipline" is plausible but risk-bounded.** EU MDR definitions make the "intended purpose" and "accessory" classification hinge on marketing/claims, not just what the object physically is. The existence of manufacturer safety warnings around retention lines and child strangulation makes it especially important that HEAD's early range avoids higher-risk tether mechanics and treats warnings/sizing/instructions as first-class product artefacts.

### Option 2 is structurally crowded by manufacturer apps

Your ASSESSMENT-02 non-shortlist rationale for the digital companion app is supported by ongoing manufacturer app capability. Cochlear's Nucleus Smart App documentation describes battery-status display and device status indicators in-app; MED‑EL's AudioKey 3 describes push notifications for low battery or coil disconnection; and Advanced Bionics' AB Remote documentation includes battery indicators and device check functions.

Given that these capabilities are integrated into the CI ecosystem (and often paired with device connectivity), an app that does not integrate with proprietary device data would have to differentiate on workflow/behavioural value rather than the core "battery/location/status" primitives users already expect from manufacturers. This supports the ASSESSMENT-02 conclusion that Option 2 is a weak primary bet at this stage.

### Option 3 is best treated as a validation channel, not the model

The scale achieved by independent sellers indicates that "handmade + marketplace" can work as a go-to-market route, but the leap from artisan production to brand-scale operations requires systematisation (patterns, sizing, QA, repeatable sourcing). This aligns with your ASSESSMENT-02 framing: Option 3 is useful tactically (fast feedback, early reviews), but it is not distinct from Option 1 so much as a channel mechanism to de-risk Option 1's initial design assumptions.

### Option 4 remains incompatible with startup-speed, yet shares a hidden edge case with Option 1

A fully "clinical/medical-grade" retention product distributed through clinics would entail heavier evidence burdens and slower channel cycles—even though this report did not identify a direct MDR classification precedent specifically for third-party textile headbands.

However, the key edge case for HEAD is that Option 1 could be pulled partially into MDR scope if marketed as an enabling accessory for CI devices, because MDR explicitly covers accessories and defines intended purpose broadly across marketing materials. The practical implication for ASSESSMENT-03 is not "avoid Option 1," but "treat regulatory posture as a first-order design constraint in product naming, claims, and IFU/warnings from day one."

### Options 5–7 remain secondary or later-stage mechanics, given observed market structure

The evidence base suggests that the CI accessory ecosystem is (a) specialised, (b) trust- and community-driven, and (c) already served through a mix of manufacturers, hearing retailers, and small sellers. In that context:

- A generic children's accessories brand would compete in a far broader, more commoditised arena while forfeiting the clinician/community referral specificity demonstrated by CI-focused guidance pages.
- A subscription replenishment model has no clear precedent identified in the CI accessory niche within this research pass, and would inherit complexity around product mix, safety, and returns logistics without a proven "why subscription" trigger.
- A marketplace/aggregator approach would likely be margin-thin and differentiation-poor given how easy it is today to find CI accessory categories on Etsy and through established hearing retailers, combined with the fact that cross-compatible product design can be a stronger moat than reselling.
